Atsuo Kanno

818 total citations
16 papers, 668 citations indexed

About

Atsuo Kanno is a scholar working on Immunology, Rheumatology and Genetics. According to data from OpenAlex, Atsuo Kanno has authored 16 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 3 papers in Rheumatology and 3 papers in Genetics. Recurrent topics in Atsuo Kanno's work include Immune Response and Inflammation (12 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (4 papers). Atsuo Kanno is often cited by papers focused on Immune Response and Inflammation (12 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (4 papers). Atsuo Kanno collaborates with scholars based in Japan, United States and Austria. Atsuo Kanno's co-authors include Kensuke Miyake, Ryutaro Fukui, Takuma Shibata, Masahiro Onji, Shin-ichiroh Saitoh, Yuji Motoi, Nobuaki Yoshida, Toru Abo, Akihiko Ito and Shigeki Sugawara and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Immunity.

In The Last Decade

Atsuo Kanno

15 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Atsuo Kanno Japan 11 563 148 88 69 41 16 668
Timothy M. Hanley United States 9 549 1.0× 204 1.4× 87 1.0× 98 1.4× 48 1.2× 17 852
Shin-ichiroh Saitoh Japan 8 522 0.9× 198 1.3× 105 1.2× 48 0.7× 43 1.0× 10 671
Nina Chevalier Germany 11 384 0.7× 134 0.9× 56 0.6× 71 1.0× 83 2.0× 25 653
Katherine Miles United Kingdom 10 547 1.0× 132 0.9× 48 0.5× 59 0.9× 45 1.1× 13 716
Dalia E. Gaddis United States 10 393 0.7× 107 0.7× 82 0.9× 24 0.3× 48 1.2× 11 526
Yvonne K. Mburu United States 11 563 1.0× 175 1.2× 107 1.2× 33 0.5× 145 3.5× 13 781
Stéphane Bühler Switzerland 18 706 1.3× 184 1.2× 66 0.8× 27 0.4× 27 0.7× 47 990
Meryem Aloulou France 14 569 1.0× 183 1.2× 80 0.9× 37 0.5× 71 1.7× 23 797
Satomi Kikkawa Japan 10 496 0.9× 155 1.0× 137 1.6× 17 0.2× 40 1.0× 10 626
Courtney J. Fleenor United States 8 337 0.6× 203 1.4× 57 0.6× 18 0.3× 36 0.9× 10 505

Countries citing papers authored by Atsuo Kanno

Since Specialization
Citations

This map shows the geographic impact of Atsuo Kanno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsuo Kanno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsuo Kanno more than expected).

Fields of papers citing papers by Atsuo Kanno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsuo Kanno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsuo Kanno. The network helps show where Atsuo Kanno may publish in the future.

Co-authorship network of co-authors of Atsuo Kanno

This figure shows the co-authorship network connecting the top 25 collaborators of Atsuo Kanno. A scholar is included among the top collaborators of Atsuo Kanno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsuo Kanno. Atsuo Kanno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Fukui, Ryutaro, Yusuke Murakami, Atsuo Kanno, et al.. (2025). Anti-human TLR7 antibody for therapeutic intervention in systemic lupus erythematosus. International Immunology. 38(1). 28–40. 1 indexed citations
2.
Matsumoto, Mitsuyuki, Masashi Maeda, Atsuo Kanno, et al.. (2024). Peripherally Administered Therapeutic One-armed Antibody Reversed Behavioral Abnormalities in a Marmoset Model of Anti-NMDAR Encephalitis. Neurology. 103(7_Supplement_1).
3.
Matsumoto, Mitsuyuki, Masashi Maeda, Atsuo Kanno, et al.. (2024). Peripherally Administered Therapeutic One-armed Antibody Reversed Behavioral Abnormalities in a Marmoset Model of Anti-NMDAR Encephalitis (S4.004). Neurology. 102(7_supplement_1). 1 indexed citations
4.
Nakamura, Koji, et al.. (2022). Potential benefit of the cathepsin S inhibitor, ASP1617, as a treatment for systemic lupus erythematosus. European Journal of Pharmacology. 919. 174826–174826. 7 indexed citations
5.
Murakami, Yusuke, Ryutaro Fukui, Reika Tanaka, et al.. (2021). Anti-TLR7 Antibody Protects Against Lupus Nephritis in NZBWF1 Mice by Targeting B Cells and Patrolling Monocytes. Frontiers in Immunology. 12. 777197–777197. 35 indexed citations
6.
Fukui, Ryutaro, Chikako Yamamoto, Fumi Matsumoto, et al.. (2018). Cleavage of Toll-Like Receptor 9 Ectodomain Is Required for In Vivo Responses to Single Strand DNA. Frontiers in Immunology. 9. 1491–1491. 14 indexed citations
7.
Saitoh, Shin-ichiroh, Atsuo Kanno, Natsuko Tanimura, et al.. (2017). TLR7 mediated viral recognition results in focal type I interferon secretion by dendritic cells. Nature Communications. 8(1). 1592–1592. 67 indexed citations
8.
Kanno, Atsuo, Natsuko Tanimura, Masayuki Ishizaki, et al.. (2015). Targeting cell surface TLR7 for therapeutic intervention in autoimmune diseases. Nature Communications. 6(1). 6119–6119. 67 indexed citations
9.
Fukui, Ryutaro, Atsuo Kanno, & Kensuke Miyake. (2015). Type I IFN Contributes to the Phenotype of Unc93b1D34A/D34A Mice by Regulating TLR7 Expression in B Cells and Dendritic Cells. The Journal of Immunology. 196(1). 416–427. 5 indexed citations
10.
Huh, Jiwon, Takuma Shibata, Misun Hwang, et al.. (2014). UNC93B1 is essential for the plasma membrane localization and signaling of Toll-like receptor 5. Proceedings of the National Academy of Sciences. 111(19). 7072–7077. 55 indexed citations
11.
Motoi, Yuji, Takuma Shibata, Koichiro Takahashi, et al.. (2014). Lipopeptides are signaled by Toll-like receptor 1, 2 and 6 in endolysosomes. International Immunology. 26(10). 563–573. 21 indexed citations
12.
Murakami, Yusuke, Ryutaro Fukui, Yuji Motoi, et al.. (2014). Roles of the Cleaved N-Terminal TLR3 Fragment and Cell Surface TLR3 in Double-Stranded RNA Sensing. The Journal of Immunology. 193(10). 5208–5217. 41 indexed citations
13.
Onji, Masahiro, Atsuo Kanno, Shin-ichiroh Saitoh, et al.. (2013). An essential role for the N-terminal fragment of Toll-like receptor 9 in DNA sensing. Nature Communications. 4(1). 75 indexed citations
14.
Kanno, Atsuo, Chikako Yamamoto, Masahiro Onji, et al.. (2013). Essential role for Toll-like receptor 7 (TLR7)-unique cysteines in an intramolecular disulfide bond, proteolytic cleavage and RNA sensing. International Immunology. 25(7). 413–422. 39 indexed citations
15.
Fukui, Ryutaro, Shin-ichiroh Saitoh, Atsuo Kanno, et al.. (2011). Unc93B1 Restricts Systemic Lethal Inflammation by Orchestrating Toll-like Receptor 7 and 9 Trafficking. Immunity. 35(1). 69–81. 165 indexed citations
16.
Itoh, Hiroshi, Toru Abo, Shigeki Sugawara, Atsuo Kanno, & Katsuo Kumagai. (1988). Age-related variation in the proportion and activity of murine liver natural killer cells and their cytotoxicity against regenerating hepatocytes.. The Journal of Immunology. 141(1). 315–323. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026